Skip to main content
Premium Trial:

Request an Annual Quote

Medicorp Buys BioCan Scientific Assets from Genomics One for $725K

NEW YORK, June 2 (GenomeWeb News) - Genomics One has sold BioCan Scientific's assets to Medicorp for CA$900,000 ($724,000), the companies said today in a statement.


Due to the sale, Canadian diagnostics maker Medicorp has now acquired "substantially all" of Genomics One's BioCan Scientific subsidiaries, the companies said. The sale closed on May 31.


The transaction has been approved by Genomics One shareholders, the companies added.


Genomics One sold those assets in order to focus on the biodefense market, the company said.

The Scan

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.